You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

Select Your Country or Region
Sepsis treatment

Hemodynamic Management in Sepsis Patients

Reduce the burden of a global health crisis. 

Everyone is at risk of developing sepsis. Globally, up to 50 million people are affected by sepsis, every year. Every 2.8 seconds, one patient dies from sepsis and associated complications. Often, it can be prevented by vaccination, clean water and hygiene, safe childbirth, and preventing hospital-acquired infections (HAIs). However, sepsis is often underdiagnosed, especially at an early stage where treatments are more successful. [1]


Sepsis is a medical emergency with high mortality rates. Sepsis survivors often suffer long-term disabilities. One out of four sepsis patients does not survive hospitalization. [2], [3]

Sepsis is defined as a dysregulated immune response to an infection that injures the body's tissues and organs. As a life-threatening organ dysfunction, sepsis can lead to shock and multi-organ failure. If not recognized early and treated promptly, sepsis often leads to death. Sepsis is the most common way to die from an infectious disease worldwide, including viruses such as SARS-CoV-2. Hospital-acquired sepsis accounts for more than 40% of mortality rates and is still one of the most common complications in Intensive Care Units. [4], [5], [6]

Hospital aquired Sepsis

60 - 80% of ICU Patients with sepsis were infected inside the hospital  [7]



Sepsis mortality

100% higher probability to die in the next 5 years [8]

Costs of sepsis

76.000€ average cost per septic patient in Germany [9]

What causes sepsis?

  • The infection is most commonly caused by infections by bacteria, fungi, viruses, or parasites. 
  • The primary sources of infections resulting in sepsis are the lungs, abdomen, urinary tract, or skin.
  • 50 % of all sepsis cases start as an infection in the lungs.
  • No definitive source is found in 35 % to 50 % of cases.
  • Endotoxins initiate a pathophysiological cascade.
  • Dysregulation of the proinflammatory response of cytokines, which promotes tissue-damaging inflammation.

Sepsis symptoms

Sepsis and SARS-CoV-2

...COVID-19 does indeed cause sepsis." [10]

Today, it's known that COVID-19 can cause severe pneumonia, other organs can be affected by SARS-CoV-2, too. Multi-organ injury, which is typical for sepsis, occurs in 2-5 % of COVID-19 patients, after approximately 8-10 days. Sepsis and its complications are reasons for high mortality amongst COVID-19 patients. Therefore, knowing and recognizing early signs of sepsis is crucial for the initiation of treatment. Timely intervention after diagnosis can save lives and prevent harm to vital organ functions. [10]


Hemodynamic sepsis management

Hemodynamic management is a key therapeutic aspect in treating patients with sepsis or septic shock. [10] 

The hemodynamic management of patients with sepsis and septic shock is an important cornerstone for treatment and resuscitation. Delayed or inadequate hemodynamic management can have serious outcomes. Hypoperfusion, tissue hypoxia, edema, and fluid overload, may lead to multiple organ failures. [11] 

Hemodynamic stabilization is crucial after a sepsis diagnosis. Deliver immediate fluid resuscitation while obtaining other important laboratory results like lactate levels, blood cultures, and antibiotics is of great importance. [12], [13]. Also,  hemodynamic monitoring can help identify the type of sepsis and supports drug management.

The goal of advanced monitoring and managing hemodynamic parameters in sepsis patients is to optimize and restore the balance between oxygen demand and supply at the tissue level. A goal-oriented therapy approach should be followed, ensuring adequate perfusion and the balance of oxygen levels, with a continuous mean arterial pressure above 65 mmHg. [11]


How to use PiCCO for sepsis therapy

PiCCO provides and monitors a number of important parameters including continuous cardiac output at the bedside which can have an impact on clinical decisions. These parameters help identify adequate fluid resuscitation, without the risk of fluid overload. PiCCO monitoring also optimizes the administration of catecholamines and vasoactive agents. 

Hemodynamic sepsis management within first 24 hours

[11], Values measured in: CI = L/min/m2 · GEDI = mL/m2 · ELWI = mL/kg · MAP = mmHg

Hemodynamic sepsis management after first 24 hours

[11], Values measured in: CI = L/min/m2 · GEDI = mL/m2 · ELWI = mL/kg · MAP = mmHg

Related articles

  • Интенсивная терапия

The Italian experience: a practical advice

Professor Salvatore Grasso, Head of the Department of Anesthesia and Resuscitation at the Faculty of Medicine and Surgery of the University of Bari Aldo Moro Polyclinic, tells his story about the worst health care situation in Italy. Watch the video and learn what he experienced firsthand during the treatment of severely ill patients, at this time, infected by an unknown virus.


  • Операционная
  • Интенсивная терапия

Наглядно о гемодинамических данных: основная информация

Гемодинамические исследования позволяют врачам получать ценную информацию. В операционной пациентам, у которых проводится хирургическое вмешательство, пристальное наблюдение всегда идет на пользу. Оптимальное пре/постоперативное введение жидкости является фактором успешного восстановления. В ОИТ жизнь пациента в критическом состоянии зависит от правильного выбора следующего этапа терапии.


  • Интенсивная терапия

Удобство использования аппарата ИВЛ влияет на безопасность пациентов

Удобство использования может повлиять на безопасность пациентов и повседневную работу персонала. В данной статье дается ссылка на исследование, посвященное взаимосвязи между удобством использования и безопасностью пациента. Вы также сможете скачать форму для сравнения, которая поможет вам при покупке нового оборудования.


  • Операционная
  • Интенсивная терапия

The Value of Advanced Hemodynamic Monitoring

Beyond Basic - with - with advanced hemodynamic parameters. Learn more about blood pressure, blood flow, preload, afterload, contractility, and pulmonary edema parameters.


  • Интенсивная терапия

Пациент на ИВЛ: почему важна диафрагма?

По словам доктора Юэна Голигера, который ссылается на недавнее исследование по данной теме, слабость диафрагмы значительно повышает вероятность осложненного или длительного отлучения от аппарата ИВЛ и больничной смертности.


  • Интенсивная терапия


Острый респираторный дистресс-синдром (ОРДС) — это серьезное заболевание легких, при котором снижается уровень кислорода в крови. Частота развития ОРДС варьируется в широких пределах.


Все справочные


  2. Iwashyna TJ., Cooke CR., Wunsch H., Kahn JM., Population burden of long-term survivorship after severe sepsis in older Americans. J Am Geriatr Soc (2012) 60:1070–1077

  3. Fleischmann-Struzek C., Mellhammar L., Rose N., et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med 46, 1552–1562 (2020).



  6. Markwart R., Saito H., Harder T. et al. Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis. Intensive Care Med 46, 1536–1551 (2020).

  7. Kissoon N., Carcillo JA., Espinosa V.,et. al. World Federation of Pediatric Intensive Care and Critical Care Societies: Global Sepsis Initiative. Pediatr Crit Care Med, 2011. 12(5): p. 494-503.

  8. Angus DC. The lingering consequences of sepsis: a hidden public health disaster? JAMA,
    2010. 304(16):1833-4.

  9. Moerer, O., Burchardi, H. Kosten der Sepsis. Anaesthesist 55;2006, 36–42


  11. Saugel B., Huber W., Nierhaus A., Kluge S., Reuter D., Wagner J., Advanced Hemodynamic Management in Patients with Septic Shock", BioMed Research International, vol. 2016, Article ID 8268569, 11 pages, 2016.

  12. Virág, M.; Leiner, T.; Rottler, M.; Ocskay, K.; Molnar, Z.Individualized Hemodynamic Management in Sepsis. J. Pers. Med. 2021, 11, 157.

  13. Levy, M.M., Evans, L.E. & Rhodes, A. The Surviving Sepsis Campaign Bundle: 2018 update. Intensive Care Med 44, 925–928 (2018).